Boston Scientific Corp (BSX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 09-2010 | 06-2010 | 03-2010 | 12-2009 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 213,000 | 624,000 | 811,000 | 519,000 | 864,000 |
| Receivables | 1,320,000 | 1,317,000 | 1,315,000 | 1,301,000 | 1,375,000 |
| Inventories | 894,000 | 923,000 | 885,000 | 906,000 | 891,000 |
| Income taxes - deferred | 429,000 | 480,000 | 550,000 | 520,000 | 572,000 |
| Other current assets | 576,000 | 0 | 0 | 0 | 578,000 |
| TOTAL | $3,615,000 | $3,556,000 | $3,987,000 | $3,747,000 | $4,599,000 |
| Non-Current Assets | |||||
| PPE Net | 1,697,000 | 1,712,000 | 1,708,000 | 1,712,000 | 1,722,000 |
| Intangibles | 16,529,000 | 16,883,000 | 16,998,000 | 17,097,000 | 18,603,000 |
| Other Non-Current Assets | 287,000 | 335,000 | 326,000 | 297,000 | 253,000 |
| TOTAL | $18,513,000 | $18,930,000 | $19,032,000 | $19,106,000 | $20,578,000 |
| Total Assets | $22,128,000 | $22,486,000 | $23,019,000 | $22,853,000 | $25,177,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 504,000 | N/A | N/A | N/A | 3,000 |
| Accounts payable and accrued liabilities | 184,000 | 195,000 | 180,000 | 232,000 | 212,000 |
| Accrued Expenses | 1,626,000 | 1,604,000 | 2,325,000 | 2,285,000 | 2,609,000 |
| Other current liabilities | 295,000 | 252,000 | 368,000 | 146,000 | 198,000 |
| TOTAL | $2,609,000 | $2,955,000 | $3,723,000 | $2,913,000 | $3,022,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 4,934,000 | 5,133,000 | 5,183,000 | 5,671,000 | 5,915,000 |
| Other Non-Current Liabilities | 1,645,000 | 1,436,000 | 1,238,000 | 1,518,000 | 2,064,000 |
| TOTAL | $8,223,000 | $8,493,000 | $8,403,000 | $9,159,000 | $9,854,000 |
| Total Liabilities | $10,832,000 | $11,448,000 | $12,126,000 | $12,072,000 | $12,876,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,523,369 | 1,520,077 | 1,516,902 | 1,516,324 | 1,511,369 |
| Common Shares | 15,000 | 15,000 | 15,000 | 15,000 | 15,000 |
| Retained earnings | -4,822,000 | -5,058,000 | -5,248,000 | -5,346,000 | -3,757,000 |
| Other shareholders' equity | -129,000 | -117,000 | -37,000 | -18,000 | -43,000 |
| TOTAL | $11,296,000 | $11,038,000 | $10,893,000 | $10,781,000 | $12,301,000 |
| Total Liabilities And Equity | $22,128,000 | $22,486,000 | $23,019,000 | $22,853,000 | $25,177,000 |